InsiderTrades

Form 4 for PRVA Privia Health Group, Inc.

Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001759655-22-000050 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-04-05 2022-04-01 PRVA Mountcastle David EVP, CFO A - Grant $0.00 +48.8K 81.1K +151% $0
D 2022-04-05 2022-04-01 PRVA Mountcastle David EVP, CFO A - Grant $0.00 +64.9K 64.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.01 par value per share 2022-04-01 A A 48,833 $0.00 81,104 D — — (F1) On April 1, 2022, the reporting person received 48,833 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.
2 Derivative Stock Option (Right to Purchase) 2022-04-01 A A 64,882 $0.00 64,882 D $26.73 · — to 2032-04-01 64,882 Common Stock (F2) On April 1, 2022, the reporting person received 64,882 stock options under the Issuer's 2021 Omnibus Incentive Plan. The stock options will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.